𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Lack of major olfactory dysfunction in MPTP-induced parkinsonism

✍ Scribed by Dr. Richard L. Doty; Anu Singh; James Tetrud; J. William Langston


Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
511 KB
Volume
32
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Topiramate reduces levodopa-induced dysk
✍ Monty A. Silverdale; S.L. Nicholson; A.R. Crossman; J.M. Brotchie πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 87 KB πŸ‘ 1 views

## Abstract Overactive AMPA receptor‐mediated transmission may be involved in the pathogenesis of levodopa‐induced dyskinesia. The mechanism of action of the anticonvulsant drug topiramate involves attenuation of AMPA receptor‐mediated transmission. In this study, the potential antidyskinetic actio

6-[18F]fluoro-L-DOPA PET studies of the
✍ Doris J. Doudet; Grace L.Y. Chan; James E. Holden; Edith G. Mcgeer; Thomas A. Ai πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 83 KB πŸ‘ 2 views

This report describes a method to assess, in vivo, the turnover of dopamine (DA) and describes its application to the evaluation of DA function in normal monkeys and monkeys with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced lesions of the DA nigro-striatal pathway. Using positron emis

Raman microspectroscopy of the brain tis
✍ C. W. Ong; Z. X. Shen; Y. He; T. Lee; S. H. Tang πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 125 KB πŸ‘ 2 views

The substantia nigra of the rostral mid-brain of a monkey was studied using Raman microspectroscopy. The white and grey matter could be clearly distinguished and their relative proportions evaluated from the Raman peaks in the 3000 cm-1 region. Raman spectra obtained from the substantia nigra for bo

Stimulation of cannabinoid receptors red
✍ Susan H. Fox; Brian Henry; Michael Hill; Alan Crossman; Jonathan Brotchie πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 291 KB πŸ‘ 1 views

Long-term treatment with levodopa in Parkinson's disease results in the development of motor fluctuations, including reduced duration of antiparkinsonian action and involuntary movements, i.e., levodopa-induced dyskinesia. Cannabinoid receptors are concentrated in the basal ganglia, and stimulation